
Published On: Oct 2023
Published On: Oct 2023
According to Business Market Insights research, the Asia Pacific decapping system market was valued at US$ 52.53 million in 2022 and is expected to reach US$ 73.38 million by 2028, registering a CAGR of 5.7% from 2022 to 2028. Accelerated demand for vaccine egg decapper in process industry and innovative product launches are the critical factors attributed to the Asia Pacific decapping system market expansion.
Large quantities of eggs are used in various manufacturing and processing industries, particularly in the pharmaceutical and biotech industries. These eggs must often be decapped for vaccine production or capsule filling process. Many existing decapping methods and devices are being adopted by the processing industries such as pharmaceutical and biotech. The Embrex Vaccine Egg Decapper (VED) from Zoetis is a semi-automated device that removes the tops of embryonated chicken eggs intended for vaccine production. The egg decapper utilizes a proprietary cutting and cleaning system that helps facilitate a clean cut and deposits shells into a waste container assisting in minimizing shell debris. Such mobile devices are ideal for small production and laboratory research facilities. Further, the Embrex egg decapper is specialized in decapping 36 or 42 eggs simultaneously, with a throughput efficiency of 5,000 to 18,000 eggs per hour with a human-machine interface (HMI) and programmable logic controller (PLC) for full system control. Therefore, once the egg decapper process is performed the specimen is collected in the tubes for further processing. Such advanced decapping technology in the process industry for specimen collection tubes accelerates the demand for decapping eggs, enhancing overall market growth.
On the contrary, technical errors and repetitive manual tasks associated with dapping system hampers the Asia Pacific decapping system market.
Based on type, the Asia Pacific decapping system market is segmented into manual, semi-automated, and automated. The automated segment held 59.1% share of Asia Pacific decapping system market in 2022, amassing US$ 31.04 million. It is projected to garner US$ 44.68 million by 2028 to expand at 6.3% CAGR during 2022–2028.
Based on application, the Asia Pacific decapping system market is segmented into tubes and vials. The tubes segment held 86.7% share of Asia Pacific decapping system market in 2022, amassing US$ 45.56 million. It is projected to garner US$ 63.77 million by 2028 to expand at 5.8% CAGR during 2022–2028.
Based on end user, the Asia Pacific decapping system market is segmented into pharmaceutical and biotech industry, CDMOs/CROs, and others. The pharmaceutical and biotech industry segment held 62.5% share of Asia Pacific decapping system market in 2022, amassing US$ 32.86 million. It is projected to garner US$ 45.62 million by 2028 to expand at 5.6% CAGR during 2022–2028.
Based on country, the Asia Pacific decapping system market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Our regional analysis states that China captured 37.1% share of Asia Pacific decapping system market in 2022. It was assessed at US$ 19.48 million in 2022 and is likely to hit US$ 27.84 million by 2028, exhibiting a CAGR of 6.1% during 2022–2028.
Key players operating in the Asia Pacific decapping system market are Agilent Technologies Inc, Azenta Inc, Cole-Parmer Instrument Co LLC, Hamilton Co, Micronic Holding BV, Sarstedt AG & Co KG, and Thermo Fisher Scientific Inc, among others.
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com